FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B

10Report
FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B

The single-dose medicine "represents important progress" as the first-ever gene therapy for the rare disorder, the FDA said.

Similar news

Share
Report

Report this article here.